These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

995 related items for PubMed ID: 23642756

  • 21. Hyperhomocysteinemia, C677T MTHFR polymorphism and ischemic stroke in Tunisian patients.
    Salem-Berrabah OB, Mrissa R, Machghoul S, Hamida AB, N'siri B, Mazigh C, Aouni Z, Louati I, Layouni S, El Oudi M, Fekih-Mrissa N, Gritli N.
    Tunis Med; 2010 Sep; 88(9):655-9. PubMed ID: 20812180
    [Abstract] [Full Text] [Related]

  • 22. Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India.
    Kumar M, Goudihalli S, Mukherjee K, Dhandapani S, Sandhir R.
    Metab Brain Dis; 2018 Oct; 33(5):1617-1624. PubMed ID: 29926428
    [Abstract] [Full Text] [Related]

  • 23. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea.
    Cho SE, Hong KS, Shin GJ, Chung WS.
    Clin Chem Lab Med; 2006 Oct; 44(9):1070-5. PubMed ID: 16958597
    [Abstract] [Full Text] [Related]

  • 24. Methylenetetrahydrofolate reductase gene polymorphism and serum homocysteine levels in nonalcoholic fatty liver disease.
    Franco Brochado MJ, Domenici FA, Candolo Martinelli Ade L, Zucoloto S, de Carvalho da Cunha SF, Vannucchi H.
    Ann Nutr Metab; 2013 Oct; 63(3):193-9. PubMed ID: 24051448
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
    Vurucu S, Demirkaya E, Kul M, Unay B, Gul D, Akin R, Gokçay E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):844-8. PubMed ID: 18234410
    [Abstract] [Full Text] [Related]

  • 26. Hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T polymorphism in cerebral veno-sinus thrombosis.
    Bharatkumar VP, Nagaraja D, Christopher R.
    Clin Appl Thromb Hemost; 2014 Jan 01; 20(1):78-83. PubMed ID: 23172871
    [Abstract] [Full Text] [Related]

  • 27. Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.
    Fekih Mrissa N, Mrad M, Klai S, Zaouali J, Sayeh A, Mazigh C, Nsiri B, Machgoul S, Gritli N, Mrissa R.
    Clin Neurol Neurosurg; 2013 Sep 01; 115(9):1657-60. PubMed ID: 23523621
    [Abstract] [Full Text] [Related]

  • 28. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E, Virgos C, Murphy M, Martorell L, Valero J, Simó JM, Joven J, Fernández-Ballart J, Labad A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep 01; 29(7):1169-74. PubMed ID: 16076517
    [Abstract] [Full Text] [Related]

  • 29. ANALYSIS OF RELATIONSHIP BETWEEN POLYMORPHISM OF MTHFR (C677T), MTHFR (A1298C), MTR (A2756G) GENES IN THE DEVELOPMENT OF ISCHEMIC STROKE IN YOUNG PATIENTS.
    Mialovytska O, Nebor Y.
    Georgian Med News; 2021 Oct 01; (319):87-92. PubMed ID: 34749329
    [Abstract] [Full Text] [Related]

  • 30. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C.
    Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I.
    Brain Res Bull; 2006 Dec 11; 71(1-3):45-50. PubMed ID: 17113927
    [Abstract] [Full Text] [Related]

  • 31. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS, Shpichinetsky V, Goldschmidt N, Atta IA, Ben-Yehuda A, Friedman G.
    Nephron; 2002 Sep 11; 92(1):120-6. PubMed ID: 12187094
    [Abstract] [Full Text] [Related]

  • 32. MTHFR C677T polymorphism and its relation to ischemic stroke in the Black Sea Turkish population.
    Uçar F, Sönmez M, Ovali E, Ozmenoglu M, Karti SS, Yilmaz M, Pakdemir A.
    Am J Hematol; 2004 May 11; 76(1):40-3. PubMed ID: 15114595
    [Abstract] [Full Text] [Related]

  • 33. [Hyperhomocysteinemia and deep-vein thrombosis].
    Qiu L, Yan SK, Song YH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec 11; 25(6):706-9. PubMed ID: 14714317
    [Abstract] [Full Text] [Related]

  • 34. Homocysteine, small-vessel disease, and atherosclerosis: an MRI study of 825 stroke patients.
    Jeon SB, Kang DW, Kim JS, Kwon SU.
    Neurology; 2014 Aug 19; 83(8):695-701. PubMed ID: 25031284
    [Abstract] [Full Text] [Related]

  • 35. Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia.
    Li ZC, Huang M, Yao QY, Lin CH, Hong BC, Wang JH, Zhang Z.
    J Integr Neurosci; 2024 Jan 10; 23(1):3. PubMed ID: 38287840
    [Abstract] [Full Text] [Related]

  • 36. Hyperhomocysteinaemia in a young woman presenting with stroke, associated with methylene tetrahydrofolate reductase C677T homozygosity.
    Saldana Chaparro R, Barron JL.
    Ann Clin Biochem; 2004 May 10; 41(Pt 3):241-4. PubMed ID: 15117441
    [Abstract] [Full Text] [Related]

  • 37. Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.
    Lin Z, Li Q, Sun Y, Huang J, Wang W, Fu J, Xu J, Zeng D.
    Lipids Health Dis; 2019 Jun 15; 18(1):143. PubMed ID: 31200713
    [Abstract] [Full Text] [Related]

  • 38. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion.
    Kim NK, Choi YK, Kang MS, Choi DH, Cha SH, An MO, Lee S, Jeung M, Ko JJ, Oh D.
    Thromb Res; 2006 Jun 15; 117(6):653-8. PubMed ID: 15985285
    [Abstract] [Full Text] [Related]

  • 39. Role of thrombotic risk factors in end-stage renal disease.
    Tripathi G, Sankhwar SN, Sharma RK, Baburaj VP, Agrawal S.
    Clin Appl Thromb Hemost; 2010 Apr 15; 16(2):132-40. PubMed ID: 19520684
    [Abstract] [Full Text] [Related]

  • 40. Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies.
    Klai S, Fekih-Mrissa N, El Housaini S, Kaabechi N, Nsiri B, Rachdi R, Gritli N.
    Blood Coagul Fibrinolysis; 2011 Jul 15; 22(5):374-8. PubMed ID: 21577095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.